First-Episode Psychosis: Flat Affect Predicts Poor Outcome

This study was supported by several entities, including Health West, Norway; the Norwegian National Research Council; Lundbeck Pharma; Eli Lilly; the U.S. National Alliance for Research on Schizophrenia and Depression; and the U.S. National Institute of Mental Health. The authors reported having no relevant conflicts of interest.